Special article
Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of Nephrology
Efectos renales adversos por inhibidores del check-point (ICP) en pacientes con cáncer. Recomendaciones del grupo de Onconefrología de la Sociedad Española de Nefrología (SEN)
Fabiola Alonsoa,
, Ángel L.M. Martín de Franciscob, Pilar Auñónc, Clara García-Carrod, Patricia Garcíae, Eduardo Gutiérrezc, Manuel Mcíae, Luis F. Quintanaf, Borja Quirogag, María José Solerh, Isidro Torregrosai, Onconephrology Group of the Spanish Society of Nephrology
Corresponding author
a Hospital Universitario Virgen Macarena, Sevilla, Spain
b Hospital Universitario Valdecilla, Santander, Spain
c Hospital Universitario Doce de Octubre, Madrid, Spain
d Hospital Clínico San Carlos, Madrid, Spain
e Hospital Universitario Candelaria, Santa Cruz de Tenerife, Spain
f Hospital Clínic Universitario, Barcelona, Spain
g Hospital Universitario La Princesa, Madrid, Spain
h Hospital Universitario Vall d’Hebron, Barcelona, Spain
i Hospital Clínico Universitario, Valencia, Spain
Ver másRead
3957
Timeswas read the article
1381
Total PDF
2576
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 157 | 135 | 292 |
| 2025 5 | 186 | 61 | 247 |
| 2025 4 | 157 | 66 | 223 |
| 2025 3 | 188 | 86 | 274 |
| 2025 2 | 132 | 67 | 199 |
| 2025 1 | 154 | 65 | 219 |
| 2024 12 | 105 | 60 | 165 |
| 2024 11 | 91 | 80 | 171 |
| 2024 10 | 109 | 100 | 209 |
| 2024 9 | 150 | 62 | 212 |
| 2024 8 | 249 | 124 | 373 |
| 2024 7 | 295 | 54 | 349 |
| 2024 6 | 106 | 61 | 167 |
| 2024 5 | 100 | 69 | 169 |
| 2024 4 | 71 | 35 | 106 |
| 2024 3 | 81 | 57 | 138 |
| 2024 2 | 79 | 54 | 133 |
| 2024 1 | 75 | 59 | 134 |
| 2023 12 | 79 | 72 | 151 |
| 2023 11 | 12 | 14 | 26 |
Show all
